{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:23:27Z","timestamp":1787952207438,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12890-016-0296-z","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T10:10:17Z","timestamp":1474971017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study"],"prefix":"10.1186","volume":"16","author":[{"name":"the Australian Scleroderma Interest Group (ASIG)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Morrisroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molla","family":"Huq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Rabusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna M.","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"issue":"3","key":"296_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.rdc.2015.04.009","volume":"41","author":"A Valenzuela","year":"2015","unstructured":"Valenzuela A, Nandagopal S, Steen VD, Chung L. Monitoring and diagnostic approaches for pulmonary arterial hypertension in patients with systemic sclerosis. Rheum Dis Clin North Am. 2015;41(3):489\u2013506.","journal-title":"Rheum Dis Clin North Am"},{"key":"296_CR2","doi-asserted-by":"crossref","unstructured":"Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, et al. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Res Ther. 2015;17:7.","DOI":"10.1186\/s13075-015-0517-5"},{"issue":"3","key":"296_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/acr.22121","volume":"66","author":"L Chung","year":"2014","unstructured":"Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, Derk C, Fischer A, Frech T, Furst DE, et al. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken). 2014;66(3):489\u201395.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"296_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","volume":"44","author":"VM Hsu","year":"2014","unstructured":"Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, Silver R, Fischer A, Hinchcliff ME, Varga J, et al. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Semin Arthritis Rheum. 2014;44(1):55\u201362.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"296_CR5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/JCN.0b013e318275330d","volume":"29","author":"LA Matura","year":"2014","unstructured":"Matura LA, McDonough A, Carroll DL. Health-related quality of life and psychological states in patients with pulmonary arterial hypertension. J Cardiovasc Nurs. 2014;29(2):178\u201384.","journal-title":"J Cardiovasc Nurs"},{"issue":"12","key":"296_CR6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.5603\/KP.2015.0242","volume":"73","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. [2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. Kardiol Pol. 2015;73(12):1127\u2013206.","journal-title":"Kardiol Pol"},{"key":"296_CR7","doi-asserted-by":"crossref","unstructured":"Quinlivan A, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker JG, et al. Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Intern Med J. 2015;45(11):1134\u201340.","DOI":"10.1111\/imj.12890"},{"issue":"2","key":"296_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ahj.2009.11.028","volume":"159","author":"A Macchia","year":"2010","unstructured":"Macchia A, Marchioli R, Tognoni G, Scarano M, Marfisi R, Tavazzi L, Rich S. Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed. Am Heart J. 2010;159(2):245\u201357.","journal-title":"Am Heart J"},{"key":"296_CR9","doi-asserted-by":"crossref","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23(5):581\u201390.","DOI":"10.1002\/art.1780230510"},{"issue":"7","key":"296_CR10","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger Jr TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573\u20136.","journal-title":"J Rheumatol"},{"issue":"25 Suppl","key":"296_CR11","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"296_CR12","first-page":"1117","volume":"33","author":"SR Johnson","year":"2006","unstructured":"Johnson SR, Glaman DD, Schentag CT, Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol. 2006;33(6):1117\u201322.","journal-title":"J Rheumatol"},{"issue":"1","key":"296_CR13","first-page":"84","volume":"25","author":"DE Furst","year":"1998","unstructured":"Furst DE, Clements PJ, Steen VD, Medsger Jr TA, Masi AT, D\u2019Angelo WA, Lachenbruch PA, Grau RG, Seibold JR. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998;25(1):84\u20138.","journal-title":"J Rheumatol"},{"issue":"1","key":"296_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11926-012-0302-2","volume":"15","author":"A Yaqub","year":"2013","unstructured":"Yaqub A, Chung L. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep. 2013;15(1):302.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"296_CR15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","volume":"60","author":"E Hachulla","year":"2009","unstructured":"Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, Mouthon L, Hatron PY, Jego P, Allanore Y, et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum. 2009;60(6):1831\u20139.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"296_CR16","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1378\/chest.124.6.2098","volume":"124","author":"L Schachna","year":"2003","unstructured":"Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in scleroderma. Chest. 2003;124(6):2098\u2013104.","journal-title":"Chest"},{"key":"296_CR17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.2002.tb04221.x","volume":"966","author":"R Scorza","year":"2002","unstructured":"Scorza R, Caronni M, Bazzi S, Nador F, Beretta L, Antonioli R, Origgi L, Ponti A, Marchini M, Vanoli M. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci. 2002;966:238\u201346.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"296_CR18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/03009740600844498","volume":"35","author":"L Beretta","year":"2006","unstructured":"Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol. 2006;35(6):468\u201371.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"296_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1445-5994.2004.00646.x","volume":"35","author":"SR Cox","year":"2005","unstructured":"Cox SR, Walker JG, Coleman M, Rischmueller M, Proudman S, Smith MD, Ahern MJ, Roberts-Thomson PJ. Isolated pulmonary hypertension in scleroderma. Intern Med J. 2005;35(1):28\u201333.","journal-title":"Intern Med J"},{"issue":"8","key":"296_CR20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","volume":"47","author":"N Hunzelmann","year":"2008","unstructured":"Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Moinzadeh P, Muller-Ladner U, Pfeiffer C, Riemekasten G, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford). 2008;47(8):1185\u201392.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"296_CR21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","volume":"136","author":"E Hachulla","year":"2009","unstructured":"Hachulla E, Launay D, Mouthon L, Sitbon O, Berezne A, Guillevin L, Hatron PY, Simonneau G, Clerson P, Humbert M. Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest. 2009;136(5):1211\u20139.","journal-title":"Chest"},{"issue":"2","key":"296_CR22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1378\/chest.10-0485","volume":"138","author":"A Campo","year":"2010","unstructured":"Campo A, Mathai SC, Girgis RE, Hassoun PM. Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest. 2010;138(2):461\u20132. author reply 462\u2013463.","journal-title":"Chest"},{"issue":"2","key":"296_CR23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","volume":"48","author":"V Steen","year":"2003","unstructured":"Steen V, Medsger Jr TA. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum. 2003;48(2):516\u201322.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"296_CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3899\/jrheum.090697","volume":"37","author":"AA Shah","year":"2010","unstructured":"Shah AA, Wigley FM, Hummers LK. Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol. 2010;37(1):98\u2013104.","journal-title":"J Rheumatol"},{"issue":"6","key":"296_CR25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/BOR.0000000000000220","volume":"27","author":"A Valenzuela","year":"2015","unstructured":"Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015;27(6):542\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"296_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/thx.2007.082719","volume":"64","author":"MP Sweet","year":"2009","unstructured":"Sweet MP, Patti MG, Hoopes C, Hays SR, Golden JA. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax. 2009;64(2):167\u201373.","journal-title":"Thorax"},{"issue":"4","key":"296_CR27","first-page":"491","volume":"244","author":"MP Sweet","year":"2006","unstructured":"Sweet MP, Herbella FA, Leard L, Hoopes C, Golden J, Hays S, Patti MG. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244(4):491\u20137.","journal-title":"Ann Surg"},{"issue":"4","key":"296_CR28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.amjmed.2009.07.033","volume":"123","author":"JS Lee","year":"2010","unstructured":"Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King Jr TE. Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med. 2010;123(4):304\u201311.","journal-title":"Am J Med"},{"issue":"5","key":"296_CR29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.autrev.2010.09.012","volume":"10","author":"G Bussone","year":"2011","unstructured":"Bussone G, Mouthon L. Interstitial lung disease in systemic sclerosis. Autoimmun Rev. 2011;10(5):248\u201355.","journal-title":"Autoimmun Rev"},{"key":"296_CR30","unstructured":"Morrisroe KB, Stevens WM, Byron J, Thakkar V, Moore O, Proudman S, Nikpour M. Anti-phospholipid antibodies in systemic sclerosis: prevalence and clinical correlations. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-133-7."},{"issue":"2","key":"296_CR31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/kel252","volume":"46","author":"C Salliot","year":"2007","unstructured":"Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, Gottenberg JE, Mariette X. Sjogren\u2019s syndrome is associated with and not secondary to systemic sclerosis. Rheumatology (Oxford). 2007;46(2):321\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"296_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1756-185X.2012.01810.x","volume":"16","author":"S Kobak","year":"2013","unstructured":"Kobak S, Oksel F, Aksu K, Kabasakal Y. The frequency of sicca symptoms and Sjogren\u2019s syndrome in patients with systemic sclerosis. Int J Rheum Dis. 2013;16(1):88\u201392.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"296_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1018845323765","volume":"42","author":"M Anselmino","year":"1997","unstructured":"Anselmino M, Zaninotto G, Costantini M, Ostuni P, Ianniello A, Boccu C, Doria A, Todesco S, Ancona E. Esophageal motor function in primary Sjogren\u2019s syndrome: correlation with dysphagia and xerostomia. Dig Dis Sci. 1997;42(1):113\u20138.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"296_CR34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/03009740801978871","volume":"37","author":"C Kampolis","year":"2008","unstructured":"Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Scand J Rheumatol. 2008;37(4):278\u201383.","journal-title":"Scand J Rheumatol"},{"issue":"6 Suppl 86","key":"296_CR35","first-page":"S-133","volume":"32","author":"KB Morrisroe","year":"2014","unstructured":"Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, et al. The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-133\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"296_CR36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","volume":"15","author":"SW Graf","year":"2012","unstructured":"Graf SW, Hakendorf P, Lester S, Patterson K, Walker JG, Smith MD, Ahern MJ, Roberts-Thomson PJ. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. Int J Rheum Dis. 2012;15(1):102\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"296_CR37","first-page":"462","volume":"25","author":"VS Negi","year":"1998","unstructured":"Negi VS, Tripathy NK, Misra R, Nityanand S. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol. 1998;25(3):462\u20136.","journal-title":"J Rheumatol"},{"issue":"12","key":"296_CR38","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1136\/ard.2011.153130","volume":"70","author":"T Grader-Beck","year":"2011","unstructured":"Grader-Beck T, Boin F, von Gunten S, Smith D, Rosen A, Bochner BS. Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease. Ann Rheum Dis. 2011;70(12):2218\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"296_CR39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.healun.2006.11.009","volume":"26","author":"AM Keogh","year":"2007","unstructured":"Keogh AM, McNeil KD, Wlodarczyk J, Gabbay E, Williams TJ. Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan. J Heart Lung Transplant. 2007;26(2):181\u20137.","journal-title":"J Heart Lung Transplant"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-016-0296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:48:10Z","timestamp":1498333690000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-016-0296-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1186\/s12890-016-0296-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]},"article-number":"134"}}